Biotech

All Articles

Vaxcyte rises on 'stunning' 31-valent PCV win against Pfizer

.Vaxcyte revealed what analysts called "remarkable" phase 1/2 information for its 31-valent pneumoco...

Recursion's mind disease trial presents insufficient evidence of effectiveness

.Recursion has actually stumbled by means of an early test of its own tech-enabled strategy to medic...

Acepodia, Pfizer click on with each other for chemistry-based tissue therapy

.Phone it a case of excellent chemistry: Acepodia, a biotech based upon Nobel Champion science, is a...

Praxis epilepsy medicine decreases seizures in phase 2 hearing

.Practice Precision Medicines has racked up yet another midphase win in epilepsy this year, with its...

Three officers surrender as Dyne messages blended data for DMD prospect

.After leaving a medical hold many years back, Dyne Therapy has actually uncovered new period 1/2 in...

Arrowhead fires off period 3 data in unusual metabolic ailment in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its own give before a prospective face-off along with Ionis...

Pfizer, Valneva present lyme health condition chance effective for second booster

.Pfizer as well as Valneva may possess about pair of even more years to wait just before they make t...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's study a chat along with Ayla Ellison, Ferocious Biotech Editor-in-Chief and Michelle Benz as ...

New records demonstrate how Bayer's asundexian failed to avoid movements

.Bayer suspended the period 3 test for its own variable XIa inhibitor asundexian behind time last ye...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is still set on taking its own multiple sclerosis (MS) med tolebrutinib to the FDA, executiv...